Coding Ahead
CasePilot
Medical Coding Assistant
CaseConsultant
Instant Email Coding Consultant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account
0 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, diffuse large B-cell lymphoma) gene analysis, common variant(s) (eg, codon 646)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Molecular genetic testing is a critical procedure used to identify specific genetic variants that may be associated with certain diseases. In the case of CPT® Code 81237, the focus is on the EZH2 gene, which encodes for a protein that plays a significant role in the regulation of gene expression through histone methylation. This gene is located on the long (q) arm of chromosome 7 at position 36.1 (7q36.1). The EZH2 gene is part of the polycomb repressive complex 2 (PRC2), which is essential for maintaining the silencing of genes that are not needed for a particular cell's function. The enzyme produced by the EZH2 gene, known as histone methyltransferase, modifies histone proteins by adding methyl groups. This modification can enhance the function of these proteins or lead to atypical functions that disrupt normal cellular processes, such as cell division and proliferation. The specific focus of this testing is on common variants at codon 646 of the EZH2 gene, which is located within the catalytic SET domain. This region is particularly sensitive to methylation changes, which can significantly impact gene function. The identification of these variants is particularly relevant in the context of diffuse large B-cell lymphoma (DLBCL), a type of cancer that arises from B-lymphocytes, which are crucial components of the immune system responsible for antibody production. DLBCL is recognized as the most prevalent form of non-Hodgkin lymphoma, predominantly affecting adults over the age of 60. It is characterized by its aggressive nature and can manifest in various locations, including lymph nodes and extranodal sites such as the gastrointestinal tract, testes, thyroid, skin, breast, bone, and brain. Symptoms of DLBCL may include rapid lymph node enlargement, fatigue, loss of appetite, weight loss, dyspnea, night sweats, and fever. The analysis performed under CPT® Code 81237 aims to pinpoint these common functional variants, which can indicate compromised gene function, by comparing gene segments to identify similarities or differences that reveal the presence of the variant, often equating to a mutation.

© Copyright 2026 Coding Ahead. All rights reserved.

CasePilot
Have a question about CPT® Code 81237?

Get instant expert-level answers from CasePilot, our coding assistant.

Register to view content

Create a free account to unlock this content

Register to view content

Create a free account to unlock this content

Register to view content

Create a free account to unlock this content

Register to view content

Create a free account to unlock this content

Register to view content

Create a free account to unlock this content

Register to view content

Create a free account to unlock this content

CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"